Prior chemoradiotherapy is associated with a higher life‐threatening complication rate after palliative insertion of metal stents in patients with oesophageal cancer
Stéphane Lecleire(Inserm), Pierre Michel(Aix-Marseille Université), Philippe Ducrotté(Hôpital Charles-Nicolle), F. Di Fiore(Hôpital Charles-Nicolle), M F Hellot(Hôpital Charles-Nicolle), M Antonietti(Université de Rouen Normandie), Emmanuel Ben-Soussan(Université de Rouen Normandie), Éric Lerebours, B Paillot(Centre Henri Becquerel)
Cited by 77
Related Papers
Definitive chemoradiotherapy with FOLFOX versus fluorouracil and cisplatin in patients with oesophageal cancer (PRODIGE5/ACCORD17): final results of a randomised, phase 2/3 trial
|The Lancet Oncology|2014|451
Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancer
|European Journal of Cancer|1997|347
The Expression and the Cellular Distribution of the Tight Junction Proteins Are Altered in Irritable Bowel Syndrome Patients With Differences According to the Disease Subtype
|The American Journal of Gastroenterology|2011|290
European society of neurogastroenterology and motility guidelines on functional constipation in adults
|Neurogastroenterology & Motility|2019|233
A neural network algorithm for detection of GI angiectasia during small-bowel capsule endoscopy
|Gastrointestinal Endoscopy|2018|208